TY - JOUR
T1 - Differences in In-Hospital and Post-Discharge Ischemic Stroke Care According to Prestroke Functional Status
AU - Wechsler, Paul M
AU - Mistry, Eva A
AU - Sucharew, Heidi
AU - Robinson, David J
AU - Stanton, Robert
AU - de Los Rios La Rosa, Felipe
AU - Mackey, Jason
AU - Ferioli, Simona
AU - Demel, Stacie L
AU - Coleman, Elisheva R
AU - Jasne, Adam
AU - Slavin, Sabreena
AU - Walsh, Kyle B
AU - Star, Michael
AU - Haverbusch, Mary
AU - Alwell, Kathleen
AU - Woo, Daniel
AU - Kleindorfer, Dawn O
AU - Kissela, Brett M
PY - 2025/6/3
Y1 - 2025/6/3
N2 - BACKGROUND: Limited data exist regarding differences in ischemic stroke care across the care continuum between patients with and without prestroke disability. We investigated differences in in-hospital and postdischarge ischemic stroke cause evaluation and treatment between patients with and without prestroke disability using population-based data in the United States.METHODS: We ascertained all adult patients (≥18 years) hospitalized with acute ischemic stroke within the Greater Cincinnati/Northern Kentucky population between January 1, 2015, and December 31, 2015. We used univariate analyses and logistic regression to compare differences in acute ischemic stroke reperfusion therapies, stroke cause evaluation, prescription of secondary stroke prevention treatments, and rehabilitation between patients with prestroke disability (modified Rankin Scale score ≥2) and those without prestroke disability (modified Rankin Scale score 0-1).RESULTS: Of 2476 ischemic stroke patients, 1326 (53%) had prestroke disability. Prestroke disability was associated with lower odds of receiving thrombolysis (adjusted odds ratio [aOR], 0.43 [95% CI, 0.28-0.68],
P<0.01) and endovascular thrombectomy (aOR, 0.32 [95% CI, 0.13-0.78],
P<0.01). Patients with prestroke disability were less likely to receive complete in-hospital stroke cause evaluation (aOR, 0.48 [95% CI, 0.33-0.69],
P<0.01) and there were small differences in antiplatelet (84% versus 87%) and statin therapy (80% versus 86%) prescribed at discharge. Those with prestroke disability were more likely to receive in-hospital (aOR, 2.6 [95% CI, 2.11-3.21],
P<0.01) and postdischarge rehabilitative therapies (aOR, 2.27 [95% CI, 1.86-2.77],
P<0.01).
CONCLUSION: Further research into factors driving medical decision-making for patients with prestroke disability is needed to optimize the entire spectrum of ischemic stroke care for this population.
AB - BACKGROUND: Limited data exist regarding differences in ischemic stroke care across the care continuum between patients with and without prestroke disability. We investigated differences in in-hospital and postdischarge ischemic stroke cause evaluation and treatment between patients with and without prestroke disability using population-based data in the United States.METHODS: We ascertained all adult patients (≥18 years) hospitalized with acute ischemic stroke within the Greater Cincinnati/Northern Kentucky population between January 1, 2015, and December 31, 2015. We used univariate analyses and logistic regression to compare differences in acute ischemic stroke reperfusion therapies, stroke cause evaluation, prescription of secondary stroke prevention treatments, and rehabilitation between patients with prestroke disability (modified Rankin Scale score ≥2) and those without prestroke disability (modified Rankin Scale score 0-1).RESULTS: Of 2476 ischemic stroke patients, 1326 (53%) had prestroke disability. Prestroke disability was associated with lower odds of receiving thrombolysis (adjusted odds ratio [aOR], 0.43 [95% CI, 0.28-0.68],
P<0.01) and endovascular thrombectomy (aOR, 0.32 [95% CI, 0.13-0.78],
P<0.01). Patients with prestroke disability were less likely to receive complete in-hospital stroke cause evaluation (aOR, 0.48 [95% CI, 0.33-0.69],
P<0.01) and there were small differences in antiplatelet (84% versus 87%) and statin therapy (80% versus 86%) prescribed at discharge. Those with prestroke disability were more likely to receive in-hospital (aOR, 2.6 [95% CI, 2.11-3.21],
P<0.01) and postdischarge rehabilitative therapies (aOR, 2.27 [95% CI, 1.86-2.77],
P<0.01).
CONCLUSION: Further research into factors driving medical decision-making for patients with prestroke disability is needed to optimize the entire spectrum of ischemic stroke care for this population.
KW - Humans
KW - Male
KW - Female
KW - Ischemic Stroke/therapy
KW - Aged
KW - Patient Discharge
KW - Middle Aged
KW - Functional Status
KW - Stroke Rehabilitation
KW - Disability Evaluation
KW - Thrombolytic Therapy
KW - Aged, 80 and over
KW - Thrombectomy
KW - Retrospective Studies
KW - Treatment Outcome
KW - Endovascular Procedures
KW - Secondary Prevention/methods
KW - Kentucky/epidemiology
U2 - 10.1161/JAHA.124.040499
DO - 10.1161/JAHA.124.040499
M3 - Article
C2 - 40417811
SN - 2047-9980
VL - 14
SP - e040499
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 11
ER -